Related references
Note: Only part of the references are listed.A Model for Identifying Cytomegalovirus in Patients With Inflammatory Bowel Disease
Jeffrey D. McCurdy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience
Satoshi Yamada et al.
BMC GASTROENTEROLOGY (2014)
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy
Rita Monterubbianesi et al.
JOURNAL OF CROHNS & COLITIS (2014)
Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis
Jong Wook Kim et al.
JOURNAL OF CROHNS & COLITIS (2014)
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2014)
Diagnosis and Treatment of Ulcerative Colitis with Cytomegalovirus Infection: Importance of Controlling Mucosal Inflammation to Prevent Cytomegalovirus Reactivation
Hiroshi Nakase et al.
INTESTINAL RESEARCH (2014)
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2
W. J. Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative Colitis
Sang Hyoung Park et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Extracorporeal Photopheresis (ECP) in Patients with Steroid-dependent Crohn's Disease: An Open-label, Multicenter, Prospective Trial
Walter Reinisch et al.
INFLAMMATORY BOWEL DISEASES (2013)
Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease: A Prospective Study
Stephane Paul et al.
INFLAMMATORY BOWEL DISEASES (2013)
Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
Hugh J. Freeman
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2013)
Clinical use of anti-TNF therapy and increased risk of infections
Tauseef Ali et al.
DRUG HEALTHCARE AND PATIENT SAFETY (2013)
Letter: mucosal PCR for cytomegalovirus in refractory ulcerative colitis
T. Yoshino et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Management of cytomegalovirus infection in inflammatory bowel diseases
Sylvie Pillet et al.
DIGESTIVE AND LIVER DISEASE (2012)
Prevalence of cytomegalovirus infection in steroid-refractory Crohn's disease
Xavier Roblin et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
David Laharie et al.
LANCET (2012)
Cytomegalovirus Load in Inflamed Intestinal Tissue Is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative Colitis
Xavier Roblin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus
H. Nakase et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization
Abderrahim Oussalah et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Cytomegalovirus Infection in Patients Who Required Colectomy for Toxic Megacolon or Severe Steroid-Refractory Ulcerative Colitis
J. Barahona-Garrido et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Cytomegalovirus Infection in Patients with Active Inflammatory Bowel Disease
John J. Kim et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
TNF-α is an Important Pathogenic Factor Contributing to Reactivation of Cytomegalovirus in Inflamed Mucosa of Colon in Patients with Ulcerative Colitis: Lesson from Clinical Experience
Hiroshi Nakase et al.
INFLAMMATORY BOWEL DISEASES (2010)
Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials
G. R. Lichtenstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
M. J. Shale et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Cytomegalovirus Disappearance After Treatment for Refractory Ulcerative Colitis in 2 Patients Treated with Infliximab and 1 Patient with Leukapheresis
Valeria Criscuoli et al.
INFLAMMATORY BOWEL DISEASES (2009)
Cytomegalovirus Infection in Ulcerative Colitis: A Prospective, Comparative Study on Prevalence and Diagnostic Strategy
Eugeni Domenech et al.
INFLAMMATORY BOWEL DISEASES (2008)
Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy
Valeria D'Ovidio et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies
Takuya Yoshino et al.
INFLAMMATORY BOWEL DISEASES (2007)
Infliximab and the risk of latent viruses reactivation in active Crohn's disease
Alessandro Lavagna et al.
INFLAMMATORY BOWEL DISEASES (2007)
Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan
Masaaki Minami et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Cytomegalovirus colitis complicating inflammatory bowel disease
Ahmed Kandiel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Cytomegalovirus ileitis and hemophagocytic syndrome associated with use of anti-tumor necrosis factor-α antibody
MM Kohara et al.
CLINICAL INFECTIOUS DISEASES (2006)
Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis
J Torre-Cisneros et al.
RHEUMATOLOGY (2005)
Cytomegalovirus hepatitis associated with use of anti tumor necrosis factor -α antibody
M Mizuta et al.
CLINICAL INFECTIOUS DISEASES (2005)
Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs
CO Simon et al.
JOURNAL OF VIROLOGY (2005)
Cytomegalovirus infection in steroid-refractory ulcerative colitis - A case-control study
N Kambham et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis
G Haerter et al.
CLINICAL INFECTIOUS DISEASES (2004)
Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy
D Helbling et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Share Paper
